Flu Shots Market

Global Flu Shots Market Size, Share & Trends Analysis Report, By Type (Influenza Virus Split Vaccines, Influenza Virus Subunit Vaccines, and Influenza Whole Virus Vaccines), By Application (Avian Influenza Virus A and Avian Influenza Virus B), Forecast (2021-2027)

Published: Mar 2022 | Report Code: OMR2026046 | Category : Healthcare Information Technology | Delivery Format: /

The global flu shots market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is likely to fuel the growth of the market includes an increase in the prevalence of flu epidemics and seasonal outbreaks. The viral infection which occurs due to flu in the respiratory system is referred to as influenza. The influenza virus travels through respiratory droplets and is contagious. It can also spread from one person to another while talking or due to physical contact. The changing character of the flu virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations globally such as the Centers for Disease Control and Prevention (CDC) have suggested vaccines such as baloxavir marboxil (Xofluza) for the treatment of influenza, and have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.

The vaccines used for influenza are made up of three different influenza viruses such as influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Moreover, an increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the major factors driving the market growth. In addition, an increase in investment by leading market players across the globe and a rise in government funding has facilitated the launch of therapeutically effective vaccines, which is another factor that is expected to augment the growth of the market during the forecast period.

Market Coverage

The market number available for – 2020-2027

Base year- 2020

Forecast period- 2021-2027

Segment Covered- 

o By Type

o By Application

Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape:  GlaxoSmithKline plc, Sanofi S.A., and Sinovac Biotech Ltd., among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Flu Shots Market Report by Segment

By Type

Influenza Virus Split Vaccines

Influenza Virus Subunit Vaccines

Influenza Whole Virus Vaccines

By Application

Aviation Influenza Virus A 

Aviation Influenza Virus B 

Global Flu Shots Market Report by Region

North America       

US

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia-Pacific    

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Latin America

Middle East and Africa